SARS-CoV-2 spike T cell responses induced upon vaccination or infection remain robust against Omicron
Covid19-Sources
Rate and severity of suspected SARS-Cov-2 reinfection in a cohort of PCR-positive COVID-19 patients
Clinical Severity of COVID-19 Patients Admitted to Hospitals in Gauteng, South Africa During the Omicron-Dominant Fourth Wave by Waasila Jassat, Salim Abdool Karim, Caroline Mudara, Richard Welch, Lovelyn Ozougwu, Michelle Groome, Nevashan Govender, Anne von Gottberg, Nicole Wolter, DATCOV Author Group, Lucille Blumberg, Cheryl Cohen :: SSRN
COVID-19: Virus erreicht nach wenigen Tagen Herz und Gehirn
Studie: No-Covid-Länder haben ihre Wirtschaft am besten geschützt
(4) Johann Holzmann auf Twitter: "#ADE (Antibody Dependent Enhancement) oder #Infektionsverstärkende Antikörper. Ein Problem bei den #COVID19 #Impfstoffen? Was ist das? Wurde es überprüft bei der Entwicklung der Impfstoffe? Und gibt es Hinweise, dass ADE ein Problem sein könnte? Ein (langer) Thread 1/n" / Twitter
Risks of myocarditis, pericarditis, and cardiac arrhythmias associated with COVID-19 vaccination or SARS-CoV-2 infection
Under-reporting of adverse drug reactions : a systematic review - PubMed
Carrageenan nasal spray may double the rate of recovery from coronavirus and influenza virus infections: Re-analysis of randomized trial data - PubMed
As India approves Corbevax, here’s all you need to know about the new COVID-19 vaccine
Genomic determinants of Furin cleavage in diverse European SARS-related bat coronaviruses
SARS-CoV-2 infection of the central nervous system in a 14-month-old child: A case report of a complete autopsy
Comparison of Stress and Suicide-Related Behaviors Among Korean Youths Before and During the COVID-19 Pandemic | Adolescent Medicine | JAMA Network Open | JAMA Network
Alarm as almost 20% of South Africa's healthcare workers contract Covid - The Mail & Guardian
Impaired Cytotoxic CD8+ T Cell Response in Elderly COVID-19 Patients | mBio
The ORF8 protein of SARS-CoV-2 mediates immune evasion through down-regulating MHC-Ι
AHA journal tones down abstract linking COVID-19 vaccines to risk of heart problems – Retraction Watch
Activity of convalescent and vaccine serum against a B.1.1.529 variant SARS-CoV-2 isolate
Vaccine effectiveness against SARS-CoV-2 infection with the Omicron or Delta variants following a two-dose or booster BNT162b2 or mRNA-1273 vaccination series: A Danish cohort study
Efficacy of a Broadly Neutralizing SARS-CoV-2 Ferritin Nanoparticle Vaccine in Nonhuman Primates
SARS-CoV-2 ferritin nanoparticle vaccine induces robust innate immune activity driving polyfunctional spike-specific T cell responses - PubMed
F423c9f4 91cb 0274 Effectiveness of COVID-19 vaccines against the Omicron (B.1.1.529) variant of concern70e8fad50074
Growing Public Health Concern of COVID-19 Chronic Olfactory Dysfunction | Public Health | JAMA Otolaryngology–Head & Neck Surgery | JAMA Network
HKUMed finds Omicron SARS-CoV-2 can infect faster and better than Delta in human bronchus but with less severe infection in lung
mRNA-based COVID-19 vaccine boosters induce neutralizing immunity against SARS- CoV-2 Omicron variant
Die Europäische Arzneimittel-Agentur bestätigte keine 5943
COVID-19: Does the infectious inoculum dose-response relationship contribute to understanding heterogeneity in disease severity and transmission dynamics?